---
schema_version: "secwatch.filing_event.v1"
accession: "0001434647-25-000015"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:40:08.407281+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Zevra appoints Alicia Secor to board; director Wendy Dixon retires

## Summary
- Director Wendy Dixon resigned effective Dec 2, 2025; no disagreement with company operations.
- Alicia Secor appointed to board as Class I director, term expiring at 2028 annual meeting.
- Secor will serve on Compensation and Audit committees; compensation per director policy.
- Secor brings 30+ years life sciences experience, including CEO roles at Atalanta and Juniper.

## SEC filing metadata
- accession: 0001434647-25-000015
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000143464725000015/0001434647-25-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000143464725000015/zvra-20251126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001434647-25-000015
- JSON: https://secwatch.observer/filing/0001434647-25-000015.json
- Plain text: https://secwatch.observer/filing/0001434647-25-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.